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1. Introduction 
Hageman factor (Factor XII) is found in mamma- 
lian blood plasma and it activates plasma prekallikrein 
directly [l-2]. It is known that snake venoms contain 
protein components related to kallikrein-kinin and 
blood-coagulation systems, so we looked for a pre- 
kallikrein activator in snake venoms. Unexpectedly, 
no prekallikrein activating activity was found in snake 
venoms, but during these studies we found a potent 
kallikrein inhibitor in the venom of Russell’s viper. 
This factor also strongly inhibited the activities of 
plasmin and trypsin. It was found to be a polypeptide 
with a molecular weight of about 7,000 and amino 
terminal aspartic acid. This paper reports the isolation 
of this proteinase inhibitor from the venom and its 
characterization. 
2. Materials and methods 
The venom of Vipera russelli (lot S62B-206) was 
obtained from Sigma Chemical Co. Bovine trypsin 
(three times crystallized) was from Worthington Bie 
chemicals Corp. a-Bungarotoxin was a preparation 
made by Dr. D. Mebs, Frankfurt (Germany) [3]. Puri- 
fied bovine plasma kalllkrein [4] and bovine plasmin 
[5] were prepared by the methods reported previous- 
ly. Commercial hog pancreatic kallikrein was further 
purified as reported previously [6]. Sephadex G-75, 
* Abbrevations: RVV, Russell’s Viper Venom; TAME, N-w 
tosyl-L-arginine methylester; SDS, sodium dodecylsulfate. 
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G-50 and SE-Sephadex C-25 (2.3 meq/g) were purchased 
from Pharmacia, Uppsala, Sweden. Polyacrylamide gel 
electrophoresis was carried out by the method of Davis 
[7] in a disc electrophoresis apparatus, analytical model 
(M and S Kiki Ltd., Japan) at pH 4.0 using 7.5% gels. 
The gels were stained with Coomassie brilliant blue 
R250 (Colab Labs., Chicago Heights, USA). Molecular 
weights were determined using SDS-polyacrylamide gel 
disc electrophoresis by the method of Shapiro et al [8]. 
Whale spermmyoglobin, bovine chymotrypsinogen-A, 
ovalbumin and horse heart cytochrome c from Schwarz- 
Mann, USA were used as marker proteins. The amino 
terminal residue was identified by following Edman’s 
phenylthiohydantoin procedure [9] and identifying 
the resulting PTH amino acids by thin-layer chromato- 
graphy on silica gel plates (Kieselgel Fzs4, Merck, 
Darmstadt, Germany). The activities of kallikreins, 
plasmin and trypsin were measured at 37” using TAME 
as substrate. For determination of inhibitory activity, 
a mixture of enzyme and inhibitor in 0.9 ml of 0.4 M 
Tris-HCl buffer, pH 8.5, was incubated for 20 min, and 
then 0.1 ml of 0.1 M TAME was added. After 30 min, 
the amount of TAME hydrolyzed was determined by 
the hydroxamate method of Roberts [lo]. One inhibi- 
tory unit is defined as the amount causing reduction 
of TAME hydrolysis by 1 pmole per min. 
3. Results 
3.1. Isolation of R VV inhibitors 
Lyophilized Russell’s viper venom (100 mg) was 
dissolved in 2 ml of elution buffer and applied to a 
Sephadex G-75 column (2.5 X 128 cm), equilibrated 
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Fig. 1. Purification of the RW inhibitor on SE-Sephadex C-25. The fraction (15 mg) with inhibitory activity from a Sephadex 
G75 column was applied to a SE-Sephadex column (2.0 X 30 cm), equilibrated with 0.04 M ammonium formate buffer, pH 4.0. 
Linear gradient elution was started with 500 ml of equilibration buffer in the mixing vessel and 0.2 M ammonium acetate buffer, 
pH 9.5, in the reservoir. Then a gradient of 0.2 M to 0.5 M buffer, pH 9.5 (500 ml each), was used to elute all adsorbed material. 
Fractions of 5 ml were collected at 4” at a flow rate of 60 ml per hr. 
with 0.04 M Tris-HCl buffer, pH 8.5, containing 0.1 
M NaCl. Elution was performed with the buffer used 
for equilibration, and 5 ml fractions were collected 
at 4” at a flow rate of 50 ml per hr. Aliquots of each 
fraction were incubated with trypsin (4 l.(g) for 20 min 
and then 0.1 ml of 0.1 M TAME was added. After 10 
min, the amount of TAME hydrolyzed was determined 
1101. 
Fractions with inhibitory activity were collected 
and lyophilized, and the buffer used as eluate was 
removed by passage through a column (2.5 X 94 cm) 
of Sephadex G-50, equilibrated with 0.1 M NI&HCOs 
solution. Fractions in the protein peak having inhibi- 
tory activity were pooled and lyophilized. The mate- 
rial obtained (15 mg) was applied to a column of SE- 
Qphadex C-25 (2.0 X 30 cm), equilibrated with 0.04 
M ammonium formate buffer, pH 4.0. Linear gradient 
elution was started with 500 ml of the equilibration 
buffer in the mixing vessel and 0.2 M ammonium 
acetate buffer, pH 9.5, in the reservoir. Then the column 
was eluted with a gradient, formed with 0.2 M buffer 
to 0.5 M, pH 9.5 (500 ml each), to elute all the adsorb- 
ed materials. Fractions of 5 ml were collected at 4” at 
a flow rate of 60 ml per hr and their inhibitory activity 
was measured as described above. The inhibitory activi- 
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ty was found in two peaks (fig. l), and the main peak 
(tubes no. 280-330) was collected and lyophilized. 
Ammonium acetate was removed from the dried mate- 
rial in vacua (0.005 mm Hg) at 40”. The overall yield 
of the inhibitor (RW inhibitor) was about 5 mg from 
100 mg of venom. 
3.2. Purity and properties of the RVV inhibitor 
As shown in fig. 2, the purified inhibitor gave a 
single homogeneous band on polyacrylamide gel elec- 
trophoresis at pH 4.0 and on SDS-polyacrylamide gel 
electrophoresis at pH 7.2. Its mobility on the gel was 
almost the same as that of a-bungarotoxin which has 
a molecular weight of 7,983 [8]. From these results 
the inhibitor seemed to be basic protein with a molec- 
ular weight of about 7,000 to 8,000. Two cycles of 
Edman degradation established the N-terminal sequence 
as Asp-Asp-. The composition of amino acid residues, 
determined with 24,48, 72 hr hydrolysates was as fol- 
lows: Lysa, His*, Arg,,, Asps, Thrs, Ser,, Glus , Pros, 
Glys, Alas, 1/2Cys,, Vali , Iler , Leu3, Tyrz andPhe4. 
No tryptophan was detected spectrophotometrically 
[ 111. Thus, the material was deduced to have a total 
of 60 amino acid residues. 
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Fig. 2. I% gel electrophoreses of the RVV inhibitor and unfractionated venom in the absence or presence of SDS. Ebctrophoresis 
was done in 7.5% polyacrylamide gel for 1.2 to 4 hr using a current of 4-6 mA per tube. (a) Russell’s viper venom (30 pg) and (b) 
RVV inhibitor (20 pg) at pH 4.5. (c) Russell’s viper venom (30 rg), (d) RVV inhibitor (5 pg) and (e) marker proteins in SDS-gel at 
pH 7.2. (1) Ovalbumin, (2) Chymotrypsinogen-A, (3) Myoglobin, (4) Cytochrome c, (5) a-Bungarotoxin. 
3.3. Inhibitory effects of the RVV inhibitor on the ac- 
tivities of kallikreins, plasmin and trypsin 
The RW inhibitor inactivated plasma nd pancreatic 
kallikreins, plasmin and trypsin and its action on trypsin 
was quite strong. A titration curve for inactivation of 
trypsin showed that 1.1 pg of RW inhibitor complete- 
ly inactivated the TAME hydrolytic activity of 4 pg of 
trypsin in 20 min at 37”. So, assuming that one mole 
of enzyme reacted with one molecule of inhibitor to 
form an enzyme-inhibitor complex, the molecular 
weight of the RW inhibitor was calculated as 6,900. 
This value is in good agreement with the molecular 
weight of the inhibitor estimated by results of SDS- 
gel electrophoresis and amino acid analysis. 
4. Discussion 
Recently, a number of proteinase inhibitors have 
been isolated from various natural sources including 
animal organs, biological fluids and plants [ 121. How- 
ever, proteinase inhibitors have not previously been 
found in secretory fluid from venomous nakes. This 
paper reports the isolation of a potent inhibitor of 
kallikrein, plasmin and trypsin from the venom of 
Russell’s viper, a member of the Viperidae. The inhibi- 
tor inactivated trypsin probably by formation of an 
enzyme-inhibitor complex in a molar ratio of 1: 1. 
Inhibitory activity similar to that of the RW inhibitor 
was also found in the venoms of several members of 
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the Elapidae. The distribution and characterization of 
these inhibitors will be reported elsewhere [ 131. 
Like the Kazal-type inhibitor and the inhibitor in 
seminal plasma, the RW inhibitor was found in a 
secretory fluid. All these inhibitors contain 56 to 6 1 
amino acid residues per molecule and have no metha 
ionine or tryptophan [ 121. However, the amino acid 
composition and N-terminal sequence of the RW in-, 
hibitor, Asp-Asp-, are different with those of the 
inhibitors so far isolated from mammalian sexual and 
pancreatic glands. Thus, in studies on the structure of 
the regions of the inhibitor molecule essential for in- 
hibitor activity, the amino acid sequence of the RVV 
inhibitor should be determined and compared with 
the structures of the other inhibitors in secretory 
fluids. Studies on the amino acid sequence and the 
inhibition spectrum of the RW inhibitor are now in 
progress. 
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